Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 529-536

  Roemer, Andreas ^a   Schwettmann, Lutz ^b   Jung, Monika ^a   Roigas, J A N ^a   Kristiansen, Glen ^a   Schnorr, Dietmar ^a   Loening, Stefan A ^a   Jung, Klaus ^a   Lichtinghagen, Ralf ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ADAMs; Quantitative real time RT PCR; Renal cell carcinoma; Survival

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; METALLOPROTEINASE; PRIMER DNA;

AGED; ARTICLE; CANCER STAGING; CHEMISTRY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL; TIME; TREATMENT OUTCOME;

AGED; BASE SEQUENCE; CARCINOMA, RENAL CELL; DNA PRIMERS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 3242799873     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.529     Document Type: Article

References (26)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53: 5-26, 2003. (Pubitemid 36163619)
2. Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M and Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061, 2001. (Pubitemid 32717537)
3. Wolfsberg TG, Primakoff P, Myles DG and White JM: ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131: 275-278, 1995.
4. Chang C and Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43, 2001.
5. Hooper NM, Trew AI, Parkin ET and Turner AJ: The role of proteolysis in Alzheimer's disease. Adv Exp Med Biol 477: 379-390, 2000. (Pubitemid 32174023)
6. Black RA and White JM: ADAMs: focus on the protease domain. Curr Opin Cell Biol 10: 654-659, 1998. (Pubitemid 28477025)
7. Seals DF and Courtneidge SA: The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17: 7-30, 2003. (Pubitemid 36062504)
8. Blobel CP: Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm Res 51: 83-84, 2002.
9. De Clerck YA, Shimada H, Taylor SM and Langley KE: Matrix metalloproteinases and their inhibitors in tumor progression. Ann NY Acad Sci 732: 222-232, 1994.
10. Primakoff P and Myles DG: The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16: 83-87, 2000. (Pubitemid 30084721)
11. Iba K, Albrechtsen R, Gilpin BJ, Loechel F and Wewer UM: Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 154: 1489-1501, 1999. (Pubitemid 29226444)
12. McCulloch DR, Harvey M and Herington AC: The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol 167: 11-21, 2000.
13. Wu E, Croucher PI and McKie N: Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun 235: 437-442, 1997. (Pubitemid 27313727)
14. Yavari R, Adida C, Bray-Ward P, Brines M and Xu T: Human metalloprotease-disintegrin Kuzbanian regulates sympathoadrenal cell fate in development and neoplasia. Hum Mol Genet 7: 1161-1167, 1998. (Pubitemid 28306882)
15. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours. Wiley-Liss, New York, pp181-182, 1997.
16. Lichtinghagen R, Musholt P, Lein M, Römer A, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA and Jung K: Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 42: 398-406, 2002. (Pubitemid 35175803)
17. Somerville RP, Oblander SA and Apte SS: Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4: 216, 2003.
18. Yokoyama H, Wada T, Kobayashi K, Kuno K, Kurihara H, Shindo T and Matsushima K: A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 null mutant mice develop renal lesions mimicking obstructive nephropathy. Nephrol Dial Transplant 17 (Suppl 9): 39-41, 2002.
19. Mahimkar RM, Baricos WH, Visaya O, Pollock AS and Lovett DH: Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney. J Am Soc Nephrol 11: 595-603, 2000. (Pubitemid 30171868)
20. DeClerck YA: Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36: 1258-1268, 2000.
21. Hagemann T, Gunawan B, Schulz M, Fuzesi L and Binder C: mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas. Eur J Cancer 37: 1839-1846, 2001. (Pubitemid 32913309)
22. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS: Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7: 3113-3119, 2001. (Pubitemid 32963832)
23. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
24. Rodriguez-Manzaneque JC, Westling J, Thai SN, Luque A, Knauper V, Murphy G, Sandy JD and Iruela-Arispe ML: ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 293: 501-508, 2002.
25. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K and Suda T: Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139: 1338-1345, 1998. (Pubitemid 28510155)
26. Eijan AM, Sandes EO, Riveros MD, Thompson S, Pasik L, Mallgrino H, Celeste F and Casabe AR: High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. Cancer 98: 262-268, 2003. (Pubitemid 36828448)